Physician profile
Daniel J Cannone
NPI 1750483962
$423,289.91
in general payments reported to CMS, 2019-2025
9 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103K · 2020: $39K · 2021: $64K · 2022: $73K · 2023: $85K · 2024: $43K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $109K · Travel and Lodging: $27K · Food and Beverage: $5,166 · Consulting Fee: $3,000 · Education: $42.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $108,850.17 |
| Travel and Lodging | $26,717.95 |
| Food and Beverage | $5,166.08 |
| Consulting Fee | $3,000.00 |
| Education | $42.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $406,624.09 | 2019-2025 | Nuplazid |
| Janssen Pharmaceuticals, INC | $10,557.11 | 2019 | |
| Sun Pharmaceutical Industries INC. | $4,433.56 | 2019 | |
| Genentech, INC. | $1,215.00 | 2022 | |
| Viatris Specialty LLC | $146.29 | 2025 | Yupelri |
| Collegium Pharmaceutical, INC. | $131.33 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $80.00 | 2019 | |
| Amarin Pharma, INC. | $65.62 | 2019 | |
| Biogen, INC. | $36.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cannone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.